350 related articles for article (PubMed ID: 29490698)
1. Clinical evaluation of haploidentical hematopoietic combined with human umbilical cord-derived mesenchymal stem cells in severe aplastic anemia.
Xu L; Liu Z; Wu Y; Yang X; Cao Y; Li X; Yan B; Li S; Da W; Wu X
Eur J Med Res; 2018 Mar; 23(1):12. PubMed ID: 29490698
[TBL] [Abstract][Full Text] [Related]
2. Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results.
Liu Z; Zhang Y; Xiao H; Yao Z; Zhang H; Liu Q; Wu B; Nie D; Li Y; Pang Y; Fan Z; Li L; Jiang Z; Duan F; Li H; Zhang P; Gao Y; Ouyang L; Yue C; Xie M; Shi C; Xiao Y; Wang S
Bone Marrow Transplant; 2017 May; 52(5):704-710. PubMed ID: 28067873
[TBL] [Abstract][Full Text] [Related]
3. [Clinical observation of haploidentical-hematopoietic stem cell transplantation combined with human umbilical cord-derived mesenchymal stem cells for severe aplastic anemia-II].
Xu LX; Liu ZY; Wu YM; Cao YB; Li XH; Yan B; Yang XL; DA WM; Wu XX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):774-8. PubMed ID: 24989293
[TBL] [Abstract][Full Text] [Related]
4. Infusion of haploidentical hematopoietic stem cells combined with mesenchymal stem cells for treatment of severe aplastic anemia in adult patients yields curative effects.
Ding L; Han DM; Zheng XL; Yan HM; Xue M; Liu J; Zhu L; Guo ZK; Mao N; Ning HM; Wang HX; Heng Zhu
Cytotherapy; 2022 Feb; 24(2):205-212. PubMed ID: 34799271
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA.
Zu Y; Zhou J; Fu Y; Fang B; Liu X; Zhang Y; Yu F; Zuo W; Zhou H; Gui R; Li Z; Liu Y; Zhao H; Zhang C; Song Y
Sci Rep; 2021 Jan; 11(1):253. PubMed ID: 33420287
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia--a single-center experience.
Wang H; Wang Z; Zheng X; Ding L; Zhu L; Yan H; Guo Z
Cytotherapy; 2013 Sep; 15(9):1118-25. PubMed ID: 23806238
[TBL] [Abstract][Full Text] [Related]
7. A study of human leukocyte antigen-haploidentical hematopoietic stem cells transplantation combined with allogenic mesenchymal stem cell infusion for treatment of severe aplastic anemia in pediatric and adolescent patients.
Ding L; Han DM; Zheng XL; Yan HM; Xue M; Liu J; Zhu L; Li S; Mao N; Guo ZK; Ning HM; Wang HX; Zhu H
Stem Cells Transl Med; 2021 Feb; 10(2):291-302. PubMed ID: 32978903
[TBL] [Abstract][Full Text] [Related]
8. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia.
Lu Y; Sun RJ; Zhao YL; Xiong M; Cao XY; Zhang JP; Wei ZJ; Zhou JR; Liu DY; Lu DP
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1881-1887. PubMed ID: 29772350
[TBL] [Abstract][Full Text] [Related]
9. Reduced intensity conditioning, combined transplantation of haploidentical hematopoietic stem cells and mesenchymal stem cells in patients with severe aplastic anemia.
Li XH; Gao CJ; Da WM; Cao YB; Wang ZH; Xu LX; Wu YM; Liu B; Liu ZY; Yan B; Li SW; Yang XL; Wu XX; Han ZC
PLoS One; 2014; 9(3):e89666. PubMed ID: 24594618
[TBL] [Abstract][Full Text] [Related]
10. Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells for severe aplastic anemia: successful engraftment and mild GVHD.
Wu Y; Cao Y; Li X; Xu L; Wang Z; Liu P; Yan P; Liu Z; Wang J; Jiang S; Wu X; Gao C; Da W; Han Z
Stem Cell Res; 2014 Jan; 12(1):132-8. PubMed ID: 24185180
[TBL] [Abstract][Full Text] [Related]
11. Donor-derived marrow mesenchymal stromal cell co-transplantation following a haploidentical hematopoietic stem cell transplantation trail to treat severe aplastic anemia in children.
Wang Z-; Yu H-; Cao F-; Liu Z-; Liu Z-; Feng W-; Liu X-; Yu Y-; Xiao Y; Li L-; Zhou J
Ann Hematol; 2019 Feb; 98(2):473-479. PubMed ID: 30341538
[TBL] [Abstract][Full Text] [Related]
12. Combination of Haploidentical Hematopoietic Stem Cell Transplantation with Umbilical Cord-Derived Mesenchymal Stem Cells in Patients with Severe Aplastic Anemia: A Retrospective Controlled Study.
Sheng XF; Li H; Hong LL; Zhuang H
Turk J Haematol; 2022 Jun; 39(2):117-129. PubMed ID: 35448935
[TBL] [Abstract][Full Text] [Related]
13. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
[TBL] [Abstract][Full Text] [Related]
14. Comparison of upfront haploidentical hematopoietic stem cell transplantation and salvage haploidentical hematopoietic stem cell transplantation after immunosuppressive therapy in children with acquired severe aplastic anemia - a multicenter study.
Luo D; Qu Y; Wang D; Zhang B; Sun M; Xiong H; Lu J; Yang R; Zhao M; Liu H; Jiang H
Front Immunol; 2024; 15():1384640. PubMed ID: 38720904
[TBL] [Abstract][Full Text] [Related]
15. [Outcome of combination of HLA-haploidentical hematopoietic SCT with an unrelated cord blood unit for 127 patients with acquired severe aplastic anemia].
Liu LM; Zhang YM; Zhou HF; Wang QY; Qiu HY; Tang XW; Han Y; Fu CC; Jin ZM; Sun AN; Miao M; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2018 Aug; 39(8):624-628. PubMed ID: 30180460
[No Abstract] [Full Text] [Related]
16. [Fludarabine-based increased-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia].
Sun C; Lin X; Huang Y; Song C; Tao Y; Tu S; Fang J; Chen T; Sun C; Wu B
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):221-4. PubMed ID: 24666488
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stromal cells as prophylaxis for graft-versus-host disease in haplo-identical hematopoietic stem cell transplantation recipients with severe aplastic anemia?-a systematic review and meta-analysis.
Li R; Tu J; Zhao J; Pan H; Fang L; Shi J
Stem Cell Res Ther; 2021 Feb; 12(1):106. PubMed ID: 33541414
[TBL] [Abstract][Full Text] [Related]
18. Optimal conditioning regimen for haplo-identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de-escalation study of TBI and ATG dose.
Lee SE; Park SS; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Lee JW
Am J Hematol; 2018 Nov; 93(11):1368-1375. PubMed ID: 30117176
[TBL] [Abstract][Full Text] [Related]
19. Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - A meta analysis.
Geng C; Liu X; Chen M; Yang C; Han B
Leuk Res; 2020 Jan; 88():106266. PubMed ID: 31743865
[TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of 76 patients with severe aplastic anemia treated with haploid hematopoietic stem cell transplantation].
Zhang Y; Zhang GX; Pang AM; Yang DL; Zhang RL; Zhai WH; Wei JL; He Y; Jiang EL; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2023 Mar; 44(3):202-210. PubMed ID: 37356981
[No Abstract] [Full Text] [Related]
[Next] [New Search]
